Compare JBTM & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JBTM | BCPC |
|---|---|---|
| Founded | 1994 | 1967 |
| Country | United States | United States |
| Employees | 11500 | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 5.6B |
| IPO Year | N/A | 1995 |
| Metric | JBTM | BCPC |
|---|---|---|
| Price | $136.29 | $163.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $180.00 | $176.00 |
| AVG Volume (30 Days) | ★ 452.3K | 204.2K |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | 0.34% | ★ 0.55% |
| EPS Growth | N/A | ★ 20.87 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $799,023,000.00 |
| Revenue This Year | $8.10 | $8.47 |
| Revenue Next Year | $4.68 | $4.89 |
| P/E Ratio | ★ N/A | $128.80 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $113.67 | $139.17 |
| 52 Week High | $170.19 | $183.90 |
| Indicator | JBTM | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 51.73 | 47.89 |
| Support Level | $121.63 | $159.11 |
| Resistance Level | $137.11 | $163.72 |
| Average True Range (ATR) | 4.47 | 3.47 |
| MACD | -0.77 | -0.39 |
| Stochastic Oscillator | 33.11 | 39.08 |
JBT Marel Corp operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Protein Solutions segment includes businesses that provide solutions for the initial stage processing and harvesting of animal proteins, mainly focusing on poultry, pork, fish, and beef. The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready-to-eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical, nutraceutical, and warehouse automation end markets. The majority of its revenue is generated from the Prepared Food and Beverage Solutions segment.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.